Results 91 to 100 of about 446,603 (195)

The Role of Rilonacept in Recurrent Pericarditis [PDF]

open access: yesHeart International, 2021
Saberio Lo, Presti   +4 more
openaire   +2 more sources

Therapy of recurrent pericarditis

open access: yesJournal of the American College of Cardiology, 2004
We read with interest the paper by Raatikka et al. [(1)][1]that gives us a useful piece of information regarding pericarditis in children. The data are relevant, particularly regarding the good long-term outcome, with no instance of constriction, in agreement with our experience in adults.
Brucato A., Brambilla G., Adler Y.
openaire   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

open access: yesBJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan   +13 more
wiley   +1 more source

Pericarditis

open access: yes, 2017
Background: Pericarditis is an important diagnosis to consider, along with various other differential diagnoses, in a patient who presents with chest pain.
Rahman, Atifur, Saraswat, Avadhesh
core  

Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 20, Page 6225-6239, October 2026.
Abstract Background and Purpose Rare but severe adverse events (AEs) associated with mRNA‐lipid nanoparticle (LNP) COVID‐19 vaccines, such as Comirnaty, include anaphylaxis and inflammatory organ disorders, but their underlying mechanisms are poorly understood. We aimed to develop an animal model to study these phenomena.
László Dézsi   +13 more
wiley   +1 more source

Side effects and ineffectiveness of standard therapy for idiopathic recurrent pericarditis: status of the problem and description of clinical cases. Case report

open access: yesТерапевтический архив
Idiopathic recurrent pericarditis is a rare pathology characterised by recurrent inflammation in the cardiac cavity. Treatment of recurrent pericarditis is empirical and based on the use of drugs with anti-inflammatory properties.
Angelina A. Petrukhina   +6 more
doaj   +1 more source

Corticosteroids for Recurrent Pericarditis [PDF]

open access: yesCirculation, 2008
We have known for decades that acute pericarditis may recur after apparent cure.1 In spite of recent advances, recurrence, after an initial attack of acute pericarditis, remains a challenge for many reasons. For example, the exact rate of recurrence is not known because many, if not most, cases go unreported, especially those that have a benign course ...
openaire   +1 more source

Recurrent pleuro-pericarditis due to gastrodiaphragmatic fistula.

open access: yes, 1990
A 61-year-old woman presented with recurrent pleuro-pericarditis following Nissen fundoplication. A diagnosis of anterior gastrodiaphragmatic fistula was made. The suspected etiology of the fistula was local ischemia.
Descamps, O S   +6 more
core  

Treatment of Recurrent Pericarditis: Case Report and Review of Literature [PDF]

open access: yes, 2007
peer reviewedBenign acute pericarditis is a common disorder. Recurrence is probably the most troublesome complication, characterized by a return of pericardial pain after recovery from an episode of typical acute pericarditis.
Pierard, Luc   +2 more
core   +1 more source

[Recurrent pericarditis as an initial manifestation of Wegener's granulomatosis.]

open access: yes, 2011
International audienceRecurrent pericarditis occur in around a quarter of patients after a first episode of acute pericarditis. Most of the cases are idiopathic or viral pericarditis or post-pericardial injury syndromes.
Seve, P.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy